DENALI

A Study to Assess the Efficacy and Safety of Budesonide/Albuterol Metered-dose Inhaler (BDA MDI/PT027) Used 4 Times Daily in Adults and Children 4 Years of Age or Older With Asthma

Name of study: 
DENALI -A Study to Assess the Efficacy and Safety of Budesonide/Albuterol Metered-dose Inhaler (BDA MDI/PT027) Used 4 Times Daily in Adults and Children 4 Years of Age or Older With Asthma

Targeted disease: 
Asthma

Purpose of study:
A Study to Assess the Efficacy and Safety of Budesonide/Albuterol Metered-dose Inhaler (BDA MDI/PT027) Used 4 Times Daily in Adults and Children 4 Years of Age or Older With Asthma (DENALI)

Is this a pre- or post- market study?: 
Pre-Market Study

Is the study of a controlled or observational design? 
Controlled

What is the funding source?: 
Industry

Where is the study being conducted?
Multi-Center Trial

Lead Institution:
Multi-Center Trial

City and State: 
Nationwide

When the study is being conducted: 
Start Date: 4/10/2019
End date: 2/28/2021

What website should a person use to register for the study?
https://denalistudy.com/?utm_source=americanlungassociation&utm_medium=082020&utm_campaign=ct 

Who should a person contact to register for the study?
Visit study website to determine closest clinical site to contact directly 

Who is sponsoring this study?
Bond Avillion 2 Development LP

What is the identifier for this study on ClinicalTrials.gov?
NCT03847896 

Page last updated: August 31, 2020

Freedom From Smoking Clinic
Toms River, NJ | Dec 07, 2020